Close

January 2010

Teaser

February 2010

Teaser

March 2010

Teaser

Cataract Surgery Today: Buy It Now

  • Abbott Buys Facet Biotech for $722 Million
    From Facet Biotech
    Abbott and Facet Biotech Corporation announced today a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline. ... (Read more)
  • Scientists Shed New Light On How Retina's Hardware Is U...
    From Medical News Today
    Biologists at New York University and the University of Würzburg have identified, in greater detail, how the retina's cellular hardware is used in color preference. The ... (Read more)
  • ISTA says FDA to review eye drug by Oct. 16
    From Associated Press
    ISTA Pharmaceuticals Inc. said Monday the Food and Drug Administration will make a regulatory decision on the once-daily eye inflammation treatment XiDay by Oct. 16. The ... (Read more)
  • Cataract risk increases with anti-depressants
    From The Times of India
    Researchers at the University of British Columbia, Vancouver Coastal Health Research Institute and McGill University have found that some anti-depressant drugs are associ... (Read more)
  • High eye pressure: monitor or treat?
    From Washington University in St. Louis
    Most people at risk for developing glaucoma due to high eye pressure do not need treatment, according to a large, multi-center study. The Ocular Hypertension Treatment St... (Read more)

Subscribe to EyewireToday.com

e-dition

Mission Statement

Cataract & Refractive Surgery Today Europe delivers cutting-edge information to cataract and refractive surgeons. Read by nearly 6,600 physicians in Western and Eastern Europe, the publication promotes continuing education by covering such topics as surgical pearls, complications management, technological advances, and practice management.

Meetings

  • Check back soon for upcoming events.